Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Supernus strikes $400M+ Adamas buyout as its top drug heads toward the patent cliff

As Supernus’ top drug inches toward the patent cliff, the central nervous system-focused drugmaker has struck an M&A deal to quickly expand its portfolio of marketed medicines.  In a $400 million buyout, Supernus is paying $8.10 per share to buy CNS drugmaker Adamas Pharmaceuticals. With the deal, Supernus gets rights to Gocovri, the first and only FDA-approved drug […]

Ipsen poaches Novartis vet Mari Scheiffele to serve as president of its international specialty care team

Amid its push to grow around the globe in oncology, rare diseases and neuroscience, Ipsen has poached a Novartis veteran to head up its international specialty care team. The drugmaker on Monday named Mari Scheiffele as an executive vice president and as its president of international specialty care. She’ll start on November 1 and work to grow the […]

AbbVie’s Botox patent lawsuit is ‘very unlikely to derail’ Revance’s rival launch: analysts

For a small company seeking to market a rival to a dominant brand, a patent lawsuit from a global pharma giant would seem to be a cause for concern. But Revance has a good chance of beating back AbbVie’s recent patent case, one team of analysts figures. After AbbVie earlier this month filed an infringement suit against Revance on […]

Jakafi maker Incyte channels blood testing anxiety in awareness ads

Incyte has captured the anxiety and fear someone with polycythemia vera (PV) feels before getting their blood count tested in a new 30-second spot, “Frozen in Time.” A man sits up in bed, tense and jittery, as his wife sleeps peacefully beside him. Memories flash all around him. Then, a voiceover intones, “When you have […]

Eli Lilly, Boehringer roll out video game for doctors to highlight cardio-renal-metabolic disease connections

Like the pipes in the plumbing of a building, the heart, kidneys and endocrine system are interwoven. Disease in one area will often affect the others. Yet specialists treating patients with cardiovascular, renal and metabolic diseases—known  collectively as CRM—too often focus only on their own areas of expertise. Drugmakers Eli Lilly and Boehringer Ingelheim want […]

Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules

Even after the global Zantac recalls of 2019 and 2020 and the associated controversy, the courtroom saga over the medicine’s risk is just getting started. This week, branded drugmakers GlaxoSmithKline, Sanofi, Pfizer and Boehringer Ingelheim lost an attempt to escape class-action lawsuits over their marketing of the decades-old drug. In a federal court in Florida, […]

Neurocrine raises a new monument to mental health in pandemic resilience campaign

Neurocrine Biosciences has turned to the arts before to raise mental health awareness, and the latest iteration of its “Monumental Moments” campaign does it again. For Mental Illness Awareness Week, Neurocrine unveiled a new, specially commissioned sculpture—”The Hug” by artist Jorge Rodriguez-Gerada—at Lincoln Center in New York City. Rodriguez-Gerada and Neurocrine Biosciences presented the nearly […]

Fierce Pharma Asia—Takeda’s narcolepsy trial problem, gene therapy pact; human error in Moderna’s COVID vaccine

Takeda’s pipeline has taken a hit as the company reported a safety signal from a midstage narcolepsy program. The Japanese pharma doubled down on gene therapy with a licensing deal with Selecta Biosciences to work on lysosomal storage disorders. Takeda and Moderna have pinpointed how contaminants landed in three lots of COVID-19 vaccines in Japan. […]

Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year

Even as many biosimilar companies await their agreed-upon launch dates for their versions of the world’s bestselling drug—AbbVie’s Humira—Alvotech is still busy battling the drug giant in court. This week, the company scored a big win. In a Wednesday decision, a federal judge in Illinois dismissed AbbVie’s trade secrets theft lawsuit against Alvotech. Previously, AbbVie […]

How can pharma grab attention in the streaming TV era? Visual storytelling, says Evoke KYNE creative head Brett

Strong visuals have always been a key ingredient in pharma marketing and communications. Without them, important health information—and audiences—can be lost amid complicated science and data. But powerful visual storytelling is even more critical now in the age of pandemic-induced Zoom fatigue and endless TV streaming options, said Colleen Brett, who was recently promoted to […]

AbbVie touts more Rinvoq data in inflammatory spinal arthritis as it awaits key FDA decisions

Despite a recent FDA label restriction, AbbVie is still churning out new data for Rinvoq in the hope that adding more evidence will back the JAK inhibitor’s megablockbuster potential. A phase 3 trial testing Rinvoq in adults with nonradiographic axial spondyloarthritis (nr-axSpA) has hit its goal as significantly more patients on the drug versus placebo […]

Pilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for wider rollout in Africa

GlaxoSmithKline has spent many years developing and testing its world-first malaria vaccine, but even after a positive recommendation from European regulators in 2015, the shot still isn’t widely deployed. That’s set to change with the World Health Organization’s (WHO’s) blessing for the vaccine. Wednesday, the WHO recommended a wider use of the shot—known as RTS,S—in children in […]